+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Gastric Cancer Treatment Market 2019-2025

  • ID: 4896919
  • Report
  • March 2019
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Mar 31st 2020
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AstraZeneca PLC
  • Bristol Myers Squibb, Co.
  • Celltrion, Inc.
  • GlaxoSmithKline PLC
  • ImmunoGen, Inc.
  • MORE
Global Gastric Cancer Treatment Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy), and by End-User (Hospitals and Clinics, Specialized Cancer Treatment Centres, and Others) and Forecast 2019-2025.

Gastric cancer treatment market is expected to grow with a CAGR of 4.9% during the forecast period. The technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the gastric cancer treatment market across the globe. Gastric cancer leads to uncontrolled progress of malignant cells that originate in stomach tissue. The main cause of developing stomach cancer is still not known exactly, however, bacterium Helicobacter Pylori is one of the key causes and also smoking & ulcer are some factors leading to stomach cancer. Other factor included such as age, diet, and stomach disease can affect the risk of developing stomach cancer. Approximately 800,000 cancer-related death is caused by gastric cancer every year, as per World Health Organization.

Stomach cancer is considered as one of the most common cancer across the globe. Symptoms of stomach cancer embrace indigestion and stomach discomfort or pain. Tests that examine the stomach and oesophagus are used to detect and diagnose stomach cancer. About 6 of every 10 people have spotted with stomach cancer each year are 65 or older. The average risk that a person will develop stomach cancer in their lifetime is about 1 in 111. This risk is higher in men than in women and can also be affected by a number of other factors. As the case increasing throughout the globe the market will also increases. According to the National Institute of Cancer, the stomach cancer is common in both men and women. Age, diet and stomach disease, including infection with Helicobacter pylori, can affect the risk of developing stomach cancer. The number of new cases of stomach cancer was 7.3 per 100,000 men and women per year based on 2010-2014 cases.

Research Methodology

The market study of the global gastric cancer treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for the pharmaceutical companies, research institutes, investment companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Gastric Cancer Treatment Market Research and Analysis by Therapy
2. Global Gastric Cancer Treatment Market Research and Analysis by End-User

The Report covers:
  • Comprehensive research methodology of the global gastric cancer treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global gastric cancer treatment market.
  • Insights about market determinants which are stimulating the global gastric cancer treatment market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AstraZeneca PLC
  • Bristol Myers Squibb, Co.
  • Celltrion, Inc.
  • GlaxoSmithKline PLC
  • ImmunoGen, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. F. Hoffmann-La Roche AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Bristol-Myers Squibb, Co.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Pfizer, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Merck & Co., Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Celltrion, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Gastric Cancer Treatment Market by Therapy
5.1.1. Chemotherapy
5.1.2. Immunotherapy
5.1.3. Radiation Therapy
5.1.4. Targeted Therapy
5.1.5. Surgery
5.2. Global Gastric Cancer Treatment Market by End-User
5.2.1. Hospitals and Clinics
5.2.2. Specialized Cancer Treatment Centres
5.2.3. Others

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Amgen, Inc.
7.3. ASLAN Pharmaceuticals Pte., Ltd.
7.4. AstraZeneca PLC
7.5. Athenex, Inc.
7.6. Bristol Myers Squibb, Co.
7.7. Celgene Corp.
7.8. Celltrion, Inc.
7.9. Eli Lilly and Co.
7.10. GlaxoSmithKline PLC
7.11. Hoffmann-La Roche AG
7.12. ImmunoGen, Inc.
7.13. Merck & Co., Inc.
7.14. Novartis AG
7.15. Oncolytics Biotech, Inc.
7.16. Otsuka Holdings Co., Ltd.
7.17. Pacific Edge, Ltd.
7.18. Pfizer, Inc.
7.19. Polaris Pharmaceuticals, Inc.
7.20. Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories, Inc.
  • Amgen, Inc.
  • ASLAN Pharmaceuticals Pte., Ltd.
  • AstraZeneca PLC
  • Athenex, Inc.
  • Bristol Myers Squibb, Co.
  • Celgene Corp.
  • Celltrion, Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • ImmunoGen, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Oncolytics Biotech, Inc.
  • Otsuka Holdings Co., Ltd.
  • Pacific Edge, Ltd.
  • Pfizer, Inc.
  • Polaris Pharmaceuticals, Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll